News – Page 561 – Endpoints News

Precision diagnostics biotech wins newest round of investor backing in bid to facilitate company expansion

4 years ago

As shares tank, Orchard once again restructures, shedding gene therapy programs and a large part of the staff

4 years ago

A team at Penn says it has slashed CAR-T cell therapy manufacturing timeframe to just 24 hours

4 years ago

Federal appeals court bats back claims Novo Nordisk’s diabetes drug triggers pancreatic cancer

4 years ago

EMA to clinical trial sponsors: Use your Covid-related flexibilities in responding to Ukraine crisis

4 years ago

Fed watchdog confirms Trump-era Covid ad campaign shenanigans — and millions misspent

4 years ago

Novartis preps launch of Leqvio campaign after Academy Awards ‘splash’

4 years ago

Peter Hotez and Maria Bottazzi's 'forgotten' vaccine approved in Botswana

4 years ago

After failing badly on the new commercialization front, Zealand slashes US staff, sends off CEO and pivots back to ...

4 years ago

SEC to propose new rules to rein in SPACs — report; mRNA startup lands $27M launch round

4 years ago

Oncolytic virus player Replimune sees progress on lead program, but follow-up candidate's effectiveness remains ...

4 years ago

Luca Santarelli's VectivBio bags $100M-plus in new funding from licensing pact, loan

4 years ago

Billionaire Athira backer closely tied to ousted CEO Leen Kawas launches an attack, demands new chief

4 years ago

Covid-19 roundup: CureVac, GSK debut second shot at pandemic vaccine; BioNTech expands Covid-19 trial

4 years ago

In a bid to push beyond financial hub status, Canary Wharf plots £500M wet lab building

4 years ago

Adagio presses forward with their FDA pitch for Covid antibody — despite Omicron flaws

4 years ago

Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply

4 years ago

Roche's I/O 2.0 dreams take a hit as TIGIT inhibitor fails PhIII

4 years ago

Chasing Bristol Myers and Biogen/Denali, CNS biotech raises $100M in dash toward clinic

4 years ago

Despite 'losing money' in Russia, Roche commits to continuing its supply of essential medicines — report

4 years ago

Without an adcomm, FDA signs off on second Covid-19 booster for those over 50

4 years ago

After raising claims BridgeBio wildly overpaid directors, the accuser wants a $4M reward

4 years ago

Purdue shells out a little more cash for a non-profit biotech working on naloxone OTC nasal spray

4 years ago

Roche's Chugai lines up a $185M deal to switch drug candidate to subcutaneous formulation

4 years ago

First page Previous page 558 559 560561562 563 564 Next page Last page